Gliotoxin (GT) is a fungal secondary metabolite that has attracted great interest due to its high biological activity since it was discovered by the 1930s. An inactive derivative of this molecule, bis(methylthio)gliotoxin (bmGT), has been proposed as an invasive aspergillosis (IA) biomarker. Nevertheless, studies regarding bmGT production among common opportunistic fungi, including the genus, are scarce and sometimes discordant. As previously reported, bmGT is produced from GT by a methyl-transferase, named as GtmA, as a negative feedback regulatory system of GT production. In order to analyze the potential of bmGT detection to enable identification of infections caused by different members of the genus we have assessed bmGT production within the genus , including , , , and , and its correlation with presence. In order to validate the relevance of our findings, we compared bmGT during culture with the presence of bmGT in sera of patients from whom the spp. were isolated. Our results indicate that most isolates produce GT and bmGT both and . In contrast, and were not able to produce GT or bmGT, although produced bmGT from a exogenous GT source. The frequency and amount of bmGT production in and isolates was lower than in . Our results suggest that this defect could be related to the culture conditions, since isolates that did not produce bmGT were able to synthetize it . In summary, our study indicates that bmGT could be very useful to specifically detect the presence of , the most prevalent agent causing IA. Concerning and a higher number of analyses from sera from infected patients will be required to reach a useful conclusion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006755PMC
http://dx.doi.org/10.3389/fmicb.2018.01246DOI Listing

Publication Analysis

Top Keywords

bmgt
13
bmgt production
12
produce bmgt
12
invasive aspergillosis
8
aspergillosis biomarker
8
bmgt produced
8
isolates produce
8
production
5
production invasive
4
biomarker bismethylthiogliotoxin
4

Similar Publications

Existing tests vs. novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases.

Chin Med J (Engl)

July 2022

Respiratory Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.

Background: Although existing mycological tests (bronchoalveolar lavage [BAL] galactomannan [GM], serum GM, serum (1,3)-β-D-glucan [BDG], and fungal culture) are widely used for diagnosing invasive pulmonary aspergillosis (IPA) in non-hematological patients with respiratory diseases, their clinical utility in this large population is actually unclear. We aimed to resolve this clinical uncertainty by evaluating the diagnostic accuracy and utility of existing tests and explore the efficacy of novel sputum-based Aspergillus assays.

Methods: Existing tests were assessed in a prospective and consecutive cohort of patients with respiratory diseases in West China Hospital between 2016 and 2019 while novel sputum assays (especially sputum GM and Aspergillus-specific lateral-flow device [LFD]) in a case-controlled subcohort.

View Article and Find Full Text PDF

Gliotoxin is a fungal secondary metabolite with impact on health and agriculture since it might act as virulence factor and contaminate human and animal food. Homologous gliotoxin (GT) gene clusters are spread across a number of fungal species although if they produce GT or other related epipolythiodioxopiperazines (ETPs) remains obscure. Using bioinformatic tools, we have identified homologous gli gene clusters similar to the GT gene cluster in several fungal species.

View Article and Find Full Text PDF

Aspergillosis remains a difficult disease to diagnose antemortem in many species, especially avian species. In the present study, banked plasma samples from various avian species were examined for gliotoxin (GT), which is a recognized key virulence factor produced during the replication of species hyphae and a secondary metabolite bis(methyl)gliotoxin (bmGT). Initially, liquid chromatography-tandem mass spectrometry methods for detecting GT and bmGT were validated in a controlled model using sera obtained from rats experimentally infected with .

View Article and Find Full Text PDF

Cryptic links between apparently unrelated metabolic systems represent potential new drug targets in fungi. Evidence of such a link between zinc and gliotoxin (GT) biosynthesis in is emerging. Expression of some genes of the GT biosynthetic gene cluster is influenced by the zinc-dependent transcription activator ZafA, zinc may relieve GT-mediated fungal growth inhibition and, surprisingly, GT biosynthesis is influenced by zinc availability.

View Article and Find Full Text PDF

Fungal sulfur uptake is required for incorporation into the sidechains of the amino acids cysteine and methionine, and is also essential for the biosynthesis of the antioxidant glutathione (GSH), -adenosylmethionine (SAM), the key source of methyl groups in cellular transmethylation reactions, and -adenosylhomocysteine (SAH). Biosynthesis of redox-active gliotoxin in the opportunistic fungal pathogen has been elucidated over the past 10 years. Some fungi which produce gliotoxin-like molecular species have undergone unexpected molecular rewiring to accommodate this high-risk biosynthetic process.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!